COVID-19 Impact on Duck Virus Enteritis Vaccine Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Duck Virus Enteritis Vaccine Industry
1.7 COVID-19 Impact: Duck Virus Enteritis Vaccine Market Trends
2 Global Duck Virus Enteritis Vaccine Quarterly Market Size Analysis
2.1 Duck Virus Enteritis Vaccine Business Impact Assessment - COVID-19
2.1.1 Global Duck Virus Enteritis Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Duck Virus Enteritis Vaccine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Duck Virus Enteritis Vaccine Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Duck Virus Enteritis Vaccine Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Duck Virus Enteritis Vaccine Factory Price by Manufacturers
3.3 Location of Key Manufacturers Duck Virus Enteritis Vaccine Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Duck Virus Enteritis Vaccine Market
3.5 Key Manufacturers Duck Virus Enteritis Vaccine Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Duck Virus Enteritis Vaccine Segments, By Type
4.1 Introduction
1.4.1 Live Vaccines
1.4.2 Killed Vaccines
4.2 By Type, Global Duck Virus Enteritis Vaccine Market Size, 2019-2021
4.2.1 By Type, Global Duck Virus Enteritis Vaccine Market Size by Type, 2020-2021
4.2.2 By Type, Global Duck Virus Enteritis Vaccine Price, 2020-2021
5 Impact of Covid-19 on Duck Virus Enteritis Vaccine Segments, By Application
5.1 Overview
5.5.1 Duck
5.5.2 Others
5.2 By Application, Global Duck Virus Enteritis Vaccine Market Size, 2019-2021
5.2.1 By Application, Global Duck Virus Enteritis Vaccine Market Size by Application, 2019-2021
5.2.2 By Application, Global Duck Virus Enteritis Vaccine Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Ceva Santé Animale
7.1.1 Ceva Santé Animale Business Overview
7.1.2 Ceva Santé Animale Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Introduction
7.1.4 Ceva Santé Animale Response to COVID-19 and Related Developments
7.2 Chengdu TECBOND Biological
7.2.1 Chengdu TECBOND Biological Business Overview
7.2.2 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Introduction
7.2.4 Chengdu TECBOND Biological Response to COVID-19 and Related Developments
7.3 Institute of Animal Health and Veterinary Biologicals
7.3.1 Institute of Animal Health and Veterinary Biologicals Business Overview
7.3.2 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Introduction
7.3.4 Institute of Animal Health and Veterinary Biologicals Response to COVID-19 and Related Developments
7.4 Institute of Veterinary Preventive Medicine
7.4.1 Institute of Veterinary Preventive Medicine Business Overview
7.4.2 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Introduction
7.4.4 Institute of Veterinary Preventive Medicine Response to COVID-19 and Related Developments
7.5 International Duck Research Cooperative
7.5.1 International Duck Research Cooperative Business Overview
7.5.2 International Duck Research Cooperative Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Introduction
7.5.4 International Duck Research Cooperative Response to COVID-19 and Related Developments
7.6 MSD Animal Health (Merck)
7.6.1 MSD Animal Health (Merck) Business Overview
7.6.2 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Introduction
7.6.4 MSD Animal Health (Merck) Response to COVID-19 and Related Developments
7.7 Ringpu (Tianjin)Bio-Pharmacy
7.7.1 Ringpu (Tianjin)Bio-Pharmacy Business Overview
7.7.2 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.7.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Introduction
7.7.4 Ringpu (Tianjin)Bio-Pharmacy Response to COVID-19 and Related Developments
7.8 Veterinary Research Institute
7.8.1 Veterinary Research Institute Business Overview
7.8.2 Veterinary Research Institute Duck Virus Enteritis Vaccine Quarterly Production and Revenue, 2020
7.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Introduction
7.8.4 Veterinary Research Institute Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Duck Virus Enteritis Vaccine Supply Chain Analysis
8.1.1 Duck Virus Enteritis Vaccine Supply Chain Analysis
8.1.2 Covid-19 Impact on Duck Virus Enteritis Vaccine Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Duck Virus Enteritis Vaccine Distribution Channels
8.2.2 Covid-19 Impact on Duck Virus Enteritis Vaccine Distribution Channels
8.2.3 Duck Virus Enteritis Vaccine Distributors
8.3 Duck Virus Enteritis Vaccine Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Duck Virus Enteritis Vaccine Assessment
Table 9. COVID-19 Impact: Duck Virus Enteritis Vaccine Market Trends
Table 10. COVID-19 Impact Global Duck Virus Enteritis Vaccine Market Size
Table 11. Global Duck Virus Enteritis Vaccine Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Duck Virus Enteritis Vaccine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Duck Virus Enteritis Vaccine Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Duck Virus Enteritis Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Duck Virus Enteritis Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Duck Virus Enteritis Vaccine Market Growth Drivers
Table 17. Global Duck Virus Enteritis Vaccine Market Restraints
Table 18. Global Duck Virus Enteritis Vaccine Market Opportunities
Table 19. Global Duck Virus Enteritis Vaccine Market Challenges
Table 20. Key Manufacturers Duck Virus Enteritis Vaccine Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Duck Virus Enteritis Vaccine Market Size, 2019 (K Units) & (US$ Million)
Table 22. Duck Virus Enteritis Vaccine Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Duck Virus Enteritis Vaccine Manufacturing Plants
Table 24. Key Manufacturers Duck Virus Enteritis Vaccine Market Served
Table 25. Date of Key Manufacturers Enter into Duck Virus Enteritis Vaccine Market
Table 26. Key Manufacturers Duck Virus Enteritis Vaccine Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Duck Virus Enteritis Vaccine Market Size by Type, 2020, (US$ Million)
Table 29. Global Duck Virus Enteritis Vaccine Market Size by Type, 2020 (K Units)
Table 30. Global Duck Virus Enteritis Vaccine Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Duck Virus Enteritis Vaccine Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Duck Virus Enteritis Vaccine Market Size by Application, 2020-2021 (K Units)
Table 33. Global Duck Virus Enteritis Vaccine Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Duck Virus Enteritis Vaccine Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Duck Virus Enteritis Vaccine Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Duck Virus Enteritis Vaccine Market Size, 2019-2021 (K Units)
Table 38. US Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Duck Virus Enteritis Vaccine Market Size, 2019-2021 (K Units)
Table 43. Germany Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Duck Virus Enteritis Vaccine Market Size, 2019-2021 (K Units)
Table 50. China Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Duck Virus Enteritis Vaccine Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Ceva Santé Animale Business Overview
Table 58. Ceva Santé Animale Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Ceva Santé Animale Duck Virus Enteritis Vaccine Product
Table 60. Ceva Santé Animale Response to COVID-19 and Related Developments
Table 61. Chengdu TECBOND Biological Business Overview
Table 62. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product
Table 64. Chengdu TECBOND Biological Response to COVID-19 and Related Developments
Table 65. Institute of Animal Health and Veterinary Biologicals Business Overview
Table 66. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product
Table 68. Institute of Animal Health and Veterinary Biologicals Response to COVID-19 and Related Developments
Table 69. Institute of Veterinary Preventive Medicine Business Overview
Table 70. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product
Table 72. Institute of Veterinary Preventive Medicine Response to COVID-19 and Related Developments
Table 73. International Duck Research Cooperative Business Overview
Table 74. International Duck Research Cooperative Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product
Table 76. International Duck Research Cooperative Response to COVID-19 and Related Developments
Table 77. MSD Animal Health (Merck) Business Overview
Table 78. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product
Table 80. MSD Animal Health (Merck) Response to COVID-19 and Related Developments
Table 81. Ringpu (Tianjin)Bio-Pharmacy Business Overview
Table 82. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product
Table 84. Ringpu (Tianjin)Bio-Pharmacy Response to COVID-19 and Related Developments
Table 85. Veterinary Research Institute Business Overview
Table 86. Veterinary Research Institute Duck Virus Enteritis Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Veterinary Research Institute Duck Virus Enteritis Vaccine Product
Table 88. Veterinary Research Institute Response to COVID-19 and Related Developments
Table 89. Duck Virus Enteritis Vaccine Distributors List
Table 90. Duck Virus Enteritis Vaccine Customers List
Table 91. Covid-19 Impact on Duck Virus Enteritis Vaccine Customers
List of FiguresFigure 1. Duck Virus Enteritis Vaccine Product Picture
Figure 2. Duck Virus Enteritis Vaccine Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Duck Virus Enteritis Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Duck Virus Enteritis Vaccine Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Duck Virus Enteritis Vaccine Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Duck Virus Enteritis Vaccine Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Duck Virus Enteritis Vaccine Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Duck Virus Enteritis Vaccine Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Duck Virus Enteritis Vaccine Market Size Market Share, 2019-2021